VEGFA and wet macular degeneration: For example, regular intravitreal injections (such as those used for current anti-VEGF treatments for wet AMD) run the risk of introducing bacterial infections into the immune-privileged eye, where an active complement system plays a significant role in protecting the organ from such insults [147].